-- Hangzhou Fuen (SHE:001312) opened 98.6% higher in its trading debut on the Shenzhen Stock Exchange.
The Chinese textile product manufacturer's shares opened at 36.51 yuan apiece, nearly double from its initial public offering price of 18.38 yuan per share.
CFRA, an independent research provider, has providedwith the following research alert. Analysts at CFRA have summarized their opinion as follows:We initiate coverage on shares of REI.UN with a 12-month target price of $22, applying a forward P/FFO multiple of 13.1x to our 2026 FFO estimate, a premium to the three-year forward average of 10.4x. We start our 2026 FFO per share estimate at $1.68 and 2027 at $1.72. We have an overall positive view on REI as it has pivoted to a pure-play necessity retail REIT after exiting all residential assets, but believe it already trades at a premium that reflects this transition. REI has near-record occupancy and strong re-leasing spreads over 15%, but is unable to grow NOI faster than 3.5% in the near term due to accelerating interest expense growth related to refinancing near-term obligations from low rates through 2027. REI's grocery-anchor focus (85% of centers, targeting 90%) and concentration in Canada's high-demographic major markets (277K population, $155K income within 5km) should provide strong cash flow that enables management to further pay down debt (currently at 8.6x net debt to adjusted EBITDA).
Shenzhen Salubris Pharmaceuticals' (SHE:002294) net profit attributable to shareholders in 2025 rose 8.3% to 651.5 million yuan from 601.6 million yuan a year earlier, according to a Shenzhen bourse filing on Tuesday.Earnings per share climbed 7.4% year on year to 0.58 yuan from 0.54 yuan.Operating revenue increased 8.5% to 4.35 billion yuan from 4.01 billion yuan in the prior year.The pharmaceutical company's shares fell by over 3% during the midday trade.
Kingfa Sci & Tech (SHA:600143) posted 2025 attributable net profit of 1.15 billion yuan, up 39% from 824.6 million yuan the previous year.Earnings per share rose to 0.4459 yuan from 0.3120 yuan, according to a Tuesday filing with the Shanghai bourse.Operating revenue rose 8.1% year over year to 65.4 billion yuan from 60.5 billion yuan.In the fourth quarter of 2025, operating revenue from modified plastic products stood at 10.2 billion yuan, according to a separate filing. Operating revenue from green petrochemical products stood at 3.37 billion yuan and from new material products was 1.30 billion yuan.Shares of the plastic products manufacturer were down 1% in recent trade.